LTR Pharma is a Clinical Stage Biopharmaceutical Company
Erectile Dysfunction (ED) is a condition in which you are unable to get or keep an erection firm enough for satisfactory sexual intercourse. ED can be a short-term or long-term problem.
SPONTAN® provides on demand delivery and faster effect. A lower dose provides less systematic exposure and reduced side effects
LTR Pharma is commercialising a ‘First in Class’ rapid treatment for Erectile Dysfunction (ED) SPONTAN® with fast-track US NDA Filing within two years
worldwide expected cases by 2025
minute effectiveness
projected global market value 2024
ED is a serious and common medical problem with significant impacts to both physical and psychological health
ED has been identified as a major factor in relationship breakdown (20%). The worldwide prevalence doubled in the last 30 years and is expected to increase to 322 million in 2025.
In the first video of our Conversation Series with sexologist and nurse practitioner Melissa Hadley Barrett, she discusses the true prevalence of erectile dysfunction across different age groups. Melissa reveals how common ED is – affecting 1 in 10 men under 40, increasing to 4 out of 5 men over
LTR Pharma has today announced its Chief Scientific and Clinical Advisor, Professor Eric Chung, has been selected to present at USANZ & ANZUNS 2025 ASM to be hosted in Perth from 1-4 March 2025. Co-hosted by the Urological Society of Australian and New Zealand (USANZ) and Australia and New Zealand
In the latest video from our Conversation Series, specialist GP Dr. Tom Silva discusses crucial considerations in clinical practice with regards to ED treatment selection and patient care. Dr. Silva explores how common side effects and delayed action can impact patient confidence, while highlighting how rapid-acting treatments, like SPONTAN, can
SPONTAN may be prescribed to eligible patients under the TGA’s Special Access Scheme. For more information, please register your details via our online form.
9/204 Alice Street, Brisbane QLD 4000
Phone: 1800 519 711